Encarnita Mariotti-Ferrandiz

Title: Encarnita Mariotti-Ferrandiz: Innovator in Immunotherapy

Introduction

Encarnita Mariotti-Ferrandiz is a notable inventor based in Paris, France. He has made significant contributions to the field of immunotherapy, particularly in the treatment of autoimmune and inflammatory disorders. His innovative work has led to the development of a unique combination therapy that leverages the properties of interleukin-2 and interleukin-1 inhibitors.

Latest Patents

Encarnita holds 1 patent for his invention titled "Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof." This patent describes a combination of interleukin-2 (IL-2) and an interleukin-1 (IL-1) inhibitor, aimed at treating autoimmune and inflammatory disorders in subjects. The invention also includes a pharmaceutical composition that comprises both IL-2 and an IL-1 inhibitor, as well as a conjugate that features IL-2 conjugated to an IL-1 inhibitor.

Career Highlights

Throughout his career, Encarnita has worked with prominent organizations such as Iltoo Pharma and Sorbonne Université. His work in these institutions has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Encarnita has collaborated with esteemed colleagues, including David Klatzmann and Jérémie Mariau. These partnerships have enriched his research and fostered innovation in the field of immunotherapy.

Conclusion

Encarnita Mariotti-Ferrandiz is a pioneering inventor whose work in immunotherapy has the potential to transform treatment options for autoimmune and inflammatory disorders. His contributions to science and medicine are noteworthy and continue to inspire future innovations.